Phase 1 Single Ascending Dose Study
Clinical trial NCT06934941 · RECRUITING
Trial details
- NCT number
- NCT06934941
- Sponsor
- Neuramedy Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-25
- Primary completion
- 2025-10-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.